1 Market Overview

1.1 Product Overview and Scope of NGS-based RNA-sequencing

1.2 Classification of NGS-based RNA-sequencing by Type

1.2.1 Overview: Global NGS-based RNA-sequencing Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global NGS-based RNA-sequencing Revenue Market Share by Type in 2020

1.2.3 Sequencing by Synthesis

1.2.4 Ion Semiconductor Sequencing

1.2.5 Single-molecule Real-time Sequencing

1.2.6 Nanopore Sequencing

1.3 Global NGS-based RNA-sequencing Market by Application

1.3.1 Overview: Global NGS-based RNA-sequencing Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Research & Academia

1.3.3 Hospitals & Clinics

1.3.4 Pharmaceutical & Biotechnology Companies

1.3.5 Others

1.4 Global NGS-based RNA-sequencing Market Size & Forecast

1.5 Global NGS-based RNA-sequencing Market Size and Forecast by Region

1.5.1 Global NGS-based RNA-sequencing Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global NGS-based RNA-sequencing Market Size by Region, (2016-2021)

1.5.3 North America NGS-based RNA-sequencing Market Size and Prospect (2016-2026)

1.5.4 Europe NGS-based RNA-sequencing Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific NGS-based RNA-sequencing Market Size and Prospect (2016-2026)

1.5.6 South America NGS-based RNA-sequencing Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa NGS-based RNA-sequencing Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 NGS-based RNA-sequencing Market Drivers

1.6.2 NGS-based RNA-sequencing Market Restraints

1.6.3 NGS-based RNA-sequencing Trends Analysis

2 Company Profiles

2.1 Illumina

2.1.1 Illumina Details

2.1.2 Illumina Major Business

2.1.3 Illumina NGS-based RNA-sequencing Product and Solutions

2.1.4 Illumina NGS-based RNA-sequencing Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 Illumina Recent Developments and Future Plans

2.2 Thermo Fischer Scientific

2.2.1 Thermo Fischer Scientific Details

2.2.2 Thermo Fischer Scientific Major Business

2.2.3 Thermo Fischer Scientific NGS-based RNA-sequencing Product and Solutions

2.2.4 Thermo Fischer Scientific NGS-based RNA-sequencing Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Thermo Fischer Scientific Recent Developments and Future Plans

2.3 Oxford Nanopore

2.3.1 Oxford Nanopore Details

2.3.2 Oxford Nanopore Major Business

2.3.3 Oxford Nanopore NGS-based RNA-sequencing Product and Solutions

2.3.4 Oxford Nanopore NGS-based RNA-sequencing Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 Oxford Nanopore Recent Developments and Future Plans

2.4 Agilent Technologies

2.4.1 Agilent Technologies Details

2.4.2 Agilent Technologies Major Business

2.4.3 Agilent Technologies NGS-based RNA-sequencing Product and Solutions

2.4.4 Agilent Technologies NGS-based RNA-sequencing Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Agilent Technologies Recent Developments and Future Plans

2.5 BGI

2.5.1 BGI Details

2.5.2 BGI Major Business

2.5.3 BGI NGS-based RNA-sequencing Product and Solutions

2.5.4 BGI NGS-based RNA-sequencing Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 BGI Recent Developments and Future Plans

2.6 PerkinElmer

2.6.1 PerkinElmer Details

2.6.2 PerkinElmer Major Business

2.6.3 PerkinElmer NGS-based RNA-sequencing Product and Solutions

2.6.4 PerkinElmer NGS-based RNA-sequencing Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 PerkinElmer Recent Developments and Future Plans

2.7 QIAGEN

2.7.1 QIAGEN Details

2.7.2 QIAGEN Major Business

2.7.3 QIAGEN NGS-based RNA-sequencing Product and Solutions

2.7.4 QIAGEN NGS-based RNA-sequencing Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 QIAGEN Recent Developments and Future Plans

2.8 Eurofins Scientific

2.8.1 Eurofins Scientific Details

2.8.2 Eurofins Scientific Major Business

2.8.3 Eurofins Scientific NGS-based RNA-sequencing Product and Solutions

2.8.4 Eurofins Scientific NGS-based RNA-sequencing Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 Eurofins Scientific Recent Developments and Future Plans

2.9 Roche

2.9.1 Roche Details

2.9.2 Roche Major Business

2.9.3 Roche NGS-based RNA-sequencing Product and Solutions

2.9.4 Roche NGS-based RNA-sequencing Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 Roche Recent Developments and Future Plans

2.10 Takara Bio

2.10.1 Takara Bio Details

2.10.2 Takara Bio Major Business

2.10.3 Takara Bio NGS-based RNA-sequencing Product and Solutions

2.10.4 Takara Bio NGS-based RNA-sequencing Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 Takara Bio Recent Developments and Future Plans

2.11 GENEWIZ

2.11.1 GENEWIZ Details

2.11.2 GENEWIZ Major Business

2.11.3 GENEWIZ NGS-based RNA-sequencing Product and Solutions

2.11.4 GENEWIZ NGS-based RNA-sequencing Revenue, Gross Margin and Market Share (2019-2021)

2.11.5 GENEWIZ Recent Developments and Future Plans

2.12 Hamilton

2.12.1 Hamilton Details

2.12.2 Hamilton Major Business

2.12.3 Hamilton NGS-based RNA-sequencing Product and Solutions

2.12.4 Hamilton NGS-based RNA-sequencing Revenue, Gross Margin and Market Share (2019-2021)

2.12.5 Hamilton Recent Developments and Future Plans

2.13 Macrogen

2.13.1 Macrogen Details

2.13.2 Macrogen Major Business

2.13.3 Macrogen NGS-based RNA-sequencing Product and Solutions

2.13.4 Macrogen NGS-based RNA-sequencing Revenue, Gross Margin and Market Share (2019-2021)

2.13.5 Macrogen Recent Developments and Future Plans

2.14 Zymo Research

2.14.1 Zymo Research Details

2.14.2 Zymo Research Major Business

2.14.3 Zymo Research NGS-based RNA-sequencing Product and Solutions

2.14.4 Zymo Research NGS-based RNA-sequencing Revenue, Gross Margin and Market Share (2019-2021)

2.14.5 Zymo Research Recent Developments and Future Plans

2.15 Tecan Genomics

2.15.1 Tecan Genomics Details

2.15.2 Tecan Genomics Major Business

2.15.3 Tecan Genomics NGS-based RNA-sequencing Product and Solutions

2.15.4 Tecan Genomics NGS-based RNA-sequencing Revenue, Gross Margin and Market Share (2019-2021)

2.15.5 Tecan Genomics Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global NGS-based RNA-sequencing Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 NGS-based RNA-sequencing Players Market Share

3.2.2 Top 10 NGS-based RNA-sequencing Players Market Share

3.2.3 Market Competition Trend

3.3 NGS-based RNA-sequencing Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global NGS-based RNA-sequencing Revenue and Market Share by Type (2016-2021)

4.2 Global NGS-based RNA-sequencing Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global NGS-based RNA-sequencing Revenue Market Share by Application (2016-2021)

5.2 NGS-based RNA-sequencing Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America NGS-based RNA-sequencing Revenue by Type (2016-2026)

6.2 North America NGS-based RNA-sequencing Revenue by Application (2016-2026)

6.3 North America NGS-based RNA-sequencing Market Size by Country

6.3.1 North America NGS-based RNA-sequencing Revenue by Country (2016-2026)

6.3.2 United States NGS-based RNA-sequencing Market Size and Forecast (2016-2026)

6.3.3 Canada NGS-based RNA-sequencing Market Size and Forecast (2016-2026)

6.3.4 Mexico NGS-based RNA-sequencing Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe NGS-based RNA-sequencing Revenue by Type (2016-2026)

7.2 Europe NGS-based RNA-sequencing Revenue by Application (2016-2026)

7.3 Europe NGS-based RNA-sequencing Market Size by Country

7.3.1 Europe NGS-based RNA-sequencing Revenue by Country (2016-2026)

7.3.2 Germany NGS-based RNA-sequencing Market Size and Forecast (2016-2026)

7.3.3 France NGS-based RNA-sequencing Market Size and Forecast (2016-2026)

7.3.4 United Kingdom NGS-based RNA-sequencing Market Size and Forecast (2016-2026)

7.3.5 Russia NGS-based RNA-sequencing Market Size and Forecast (2016-2026)

7.3.6 Italy NGS-based RNA-sequencing Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific NGS-based RNA-sequencing Revenue by Type (2016-2026)

8.2 Asia-Pacific NGS-based RNA-sequencing Revenue by Application (2016-2026)

8.3 Asia-Pacific NGS-based RNA-sequencing Market Size by Region

8.3.1 Asia-Pacific NGS-based RNA-sequencing Revenue by Region (2016-2026)

8.3.2 China NGS-based RNA-sequencing Market Size and Forecast (2016-2026)

8.3.3 Japan NGS-based RNA-sequencing Market Size and Forecast (2016-2026)

8.3.4 South Korea NGS-based RNA-sequencing Market Size and Forecast (2016-2026)

8.3.5 India NGS-based RNA-sequencing Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia NGS-based RNA-sequencing Market Size and Forecast (2016-2026)

8.3.7 Australia NGS-based RNA-sequencing Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America NGS-based RNA-sequencing Revenue by Type (2016-2026)

9.2 South America NGS-based RNA-sequencing Revenue by Application (2016-2026)

9.3 South America NGS-based RNA-sequencing Market Size by Country

9.3.1 South America NGS-based RNA-sequencing Revenue by Country (2016-2026)

9.3.2 Brazil NGS-based RNA-sequencing Market Size and Forecast (2016-2026)

9.3.3 Argentina NGS-based RNA-sequencing Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa NGS-based RNA-sequencing Revenue by Type (2016-2026)

10.2 Middle East & Africa NGS-based RNA-sequencing Revenue by Application (2016-2026)

10.3 Middle East & Africa NGS-based RNA-sequencing Market Size by Country

10.3.1 Middle East & Africa NGS-based RNA-sequencing Revenue by Country (2016-2026)

10.3.2 Turkey NGS-based RNA-sequencing Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia NGS-based RNA-sequencing Market Size and Forecast (2016-2026)

10.3.4 UAE NGS-based RNA-sequencing Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global NGS-based RNA-sequencing Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global NGS-based RNA-sequencing Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market NGS-based RNA-sequencing Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global NGS-based RNA-sequencing Revenue (USD Million) by Region (2016-2021)

Table 5. Global NGS-based RNA-sequencing Revenue Market Share by Region (2021-2026)

Table 6. Illumina Corporate Information, Head Office, and Major Competitors

Table 7. Illumina Major Business

Table 8. Illumina NGS-based RNA-sequencing Product and Solutions

Table 9. Illumina NGS-based RNA-sequencing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Thermo Fischer Scientific Corporate Information, Head Office, and Major Competitors

Table 11. Thermo Fischer Scientific Major Business

Table 12. Thermo Fischer Scientific NGS-based RNA-sequencing Product and Solutions

Table 13. Thermo Fischer Scientific NGS-based RNA-sequencing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. Oxford Nanopore Corporate Information, Head Office, and Major Competitors

Table 15. Oxford Nanopore Major Business

Table 16. Oxford Nanopore NGS-based RNA-sequencing Product and Solutions

Table 17. Oxford Nanopore NGS-based RNA-sequencing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. Agilent Technologies Corporate Information, Head Office, and Major Competitors

Table 19. Agilent Technologies Major Business

Table 20. Agilent Technologies NGS-based RNA-sequencing Product and Solutions

Table 21. Agilent Technologies NGS-based RNA-sequencing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. BGI Corporate Information, Head Office, and Major Competitors

Table 23. BGI Major Business

Table 24. BGI NGS-based RNA-sequencing Product and Solutions

Table 25. BGI NGS-based RNA-sequencing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. PerkinElmer Corporate Information, Head Office, and Major Competitors

Table 27. PerkinElmer Major Business

Table 28. PerkinElmer NGS-based RNA-sequencing Product and Solutions

Table 29. PerkinElmer NGS-based RNA-sequencing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. QIAGEN Corporate Information, Head Office, and Major Competitors

Table 31. QIAGEN Major Business

Table 32. QIAGEN NGS-based RNA-sequencing Product and Solutions

Table 33. QIAGEN NGS-based RNA-sequencing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. Eurofins Scientific Corporate Information, Head Office, and Major Competitors

Table 35. Eurofins Scientific Major Business

Table 36. Eurofins Scientific NGS-based RNA-sequencing Product and Solutions

Table 37. Eurofins Scientific NGS-based RNA-sequencing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. Roche Corporate Information, Head Office, and Major Competitors

Table 39. Roche Major Business

Table 40. Roche NGS-based RNA-sequencing Product and Solutions

Table 41. Roche NGS-based RNA-sequencing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. Takara Bio Corporate Information, Head Office, and Major Competitors

Table 43. Takara Bio Major Business

Table 44. Takara Bio NGS-based RNA-sequencing Product and Solutions

Table 45. Takara Bio NGS-based RNA-sequencing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. GENEWIZ Corporate Information, Head Office, and Major Competitors

Table 47. GENEWIZ Major Business

Table 48. GENEWIZ NGS-based RNA-sequencing Product and Solutions

Table 49. GENEWIZ NGS-based RNA-sequencing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 50. Hamilton Corporate Information, Head Office, and Major Competitors

Table 51. Hamilton Major Business

Table 52. Hamilton NGS-based RNA-sequencing Product and Solutions

Table 53. Hamilton NGS-based RNA-sequencing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 54. Macrogen Corporate Information, Head Office, and Major Competitors

Table 55. Macrogen Major Business

Table 56. Macrogen NGS-based RNA-sequencing Product and Solutions

Table 57. Macrogen NGS-based RNA-sequencing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 58. Zymo Research Corporate Information, Head Office, and Major Competitors

Table 59. Zymo Research Major Business

Table 60. Zymo Research NGS-based RNA-sequencing Product and Solutions

Table 61. Zymo Research NGS-based RNA-sequencing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 62. Tecan Genomics Corporate Information, Head Office, and Major Competitors

Table 63. Tecan Genomics Major Business

Table 64. Tecan Genomics NGS-based RNA-sequencing Product and Solutions

Table 65. Tecan Genomics NGS-based RNA-sequencing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 66. Global NGS-based RNA-sequencing Revenue (USD Million) by Players (2019-2021)

Table 67. Global NGS-based RNA-sequencing Revenue Share by Players (2019-2021)

Table 68. Breakdown of NGS-based RNA-sequencing by Company Type (Tier 1, Tier 2 and Tier 3)

Table 69. NGS-based RNA-sequencing Players Head Office, Products and Services Provided

Table 70. NGS-based RNA-sequencing Mergers & Acquisitions in the Past Five Years

Table 71. NGS-based RNA-sequencing New Entrants and Expansion Plans

Table 72. Global NGS-based RNA-sequencing Revenue (USD Million) by Type (2016-2021)

Table 73. Global NGS-based RNA-sequencing Revenue Share by Type (2016-2021)

Table 74. Global NGS-based RNA-sequencing Revenue Forecast by Type (2021-2026)

Table 75. Global NGS-based RNA-sequencing Revenue by Application (2016-2021)

Table 76. Global NGS-based RNA-sequencing Revenue Forecast by Application (2021-2026)

Table 77. North America NGS-based RNA-sequencing Revenue by Type (2016-2021) & (USD Million)

Table 78. North America NGS-based RNA-sequencing Revenue by Type (2021-2026) & (USD Million)

Table 79. North America NGS-based RNA-sequencing Revenue by Application (2016-2021) & (USD Million)

Table 80. North America NGS-based RNA-sequencing Revenue by Application (2021-2026) & (USD Million)

Table 81. North America NGS-based RNA-sequencing Revenue by Country (2016-2021) & (USD Million)

Table 82. North America NGS-based RNA-sequencing Revenue by Country (2021-2026) & (USD Million)

Table 83. Europe NGS-based RNA-sequencing Revenue by Type (2016-2021) & (USD Million)

Table 84. Europe NGS-based RNA-sequencing Revenue by Type (2021-2026) & (USD Million)

Table 85. Europe NGS-based RNA-sequencing Revenue by Application (2016-2021) & (USD Million)

Table 86. Europe NGS-based RNA-sequencing Revenue by Application (2021-2026) & (USD Million)

Table 87. Europe NGS-based RNA-sequencing Revenue by Country (2016-2021) & (USD Million)

Table 88. Europe NGS-based RNA-sequencing Revenue by Country (2021-2026) & (USD Million)

Table 89. Asia-Pacific NGS-based RNA-sequencing Revenue by Type (2016-2021) & (USD Million)

Table 90. Asia-Pacific NGS-based RNA-sequencing Revenue by Type (2021-2026) & (USD Million)

Table 91. Asia-Pacific NGS-based RNA-sequencing Revenue by Application (2016-2021) & (USD Million)

Table 92. Asia-Pacific NGS-based RNA-sequencing Revenue by Application (2021-2026) & (USD Million)

Table 93. Asia-Pacific NGS-based RNA-sequencing Revenue by Region (2016-2021) & (USD Million)

Table 94. Asia-Pacific NGS-based RNA-sequencing Revenue by Region (2021-2026) & (USD Million)

Table 95. South America NGS-based RNA-sequencing Revenue by Type (2016-2021) & (USD Million)

Table 96. South America NGS-based RNA-sequencing Revenue by Type (2021-2026) & (USD Million)

Table 97. South America NGS-based RNA-sequencing Revenue by Application (2016-2021) & (USD Million)

Table 98. South America NGS-based RNA-sequencing Revenue by Application (2021-2026) & (USD Million)

Table 99. South America NGS-based RNA-sequencing Revenue by Country (2016-2021) & (USD Million)

Table 100. South America NGS-based RNA-sequencing Revenue by Country (2021-2026) & (USD Million)

Table 101. Middle East & Africa NGS-based RNA-sequencing Revenue by Type (2016-2021) & (USD Million)

Table 102. Middle East & Africa NGS-based RNA-sequencing Revenue by Type (2021-2026) & (USD Million)

Table 103. Middle East & Africa NGS-based RNA-sequencing Revenue by Application (2016-2021) & (USD Million)

Table 104. Middle East & Africa NGS-based RNA-sequencing Revenue by Application (2021-2026) & (USD Million)

Table 105. Middle East & Africa NGS-based RNA-sequencing Revenue by Country (2016-2021) & (USD Million)

Table 106. Middle East & Africa NGS-based RNA-sequencing Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. NGS-based RNA-sequencing Picture

Figure 2. Global NGS-based RNA-sequencing Revenue Market Share by Type in 2020

Figure 3. Sequencing by Synthesis

Figure 4. Ion Semiconductor Sequencing

Figure 5. Single-molecule Real-time Sequencing

Figure 6. Nanopore Sequencing

Figure 7. NGS-based RNA-sequencing Revenue Market Share by Application in 2020

Figure 8. Research & Academia Picture

Figure 9. Hospitals & Clinics Picture

Figure 10. Pharmaceutical & Biotechnology Companies Picture

Figure 11. Others Picture

Figure 12. Global NGS-based RNA-sequencing Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 13. Global NGS-based RNA-sequencing Revenue and Forecast (2016-2026) & (USD Million)

Figure 14. Global NGS-based RNA-sequencing Revenue Market Share by Region (2016-2026)

Figure 15. Global NGS-based RNA-sequencing Revenue Market Share by Region in 2020

Figure 16. North America NGS-based RNA-sequencing Revenue (USD Million) and Growth Rate (2016-2026)

Figure 17. Europe NGS-based RNA-sequencing Revenue (USD Million) and Growth Rate (2016-2026)

Figure 18. Asia-Pacific NGS-based RNA-sequencing Revenue (USD Million) and Growth Rate (2016-2026)

Figure 19. South America NGS-based RNA-sequencing Revenue (USD Million) and Growth Rate (2016-2026)

Figure 20. Middle East and Africa NGS-based RNA-sequencing Revenue (USD Million) and Growth Rate (2016-2026)

Figure 21. NGS-based RNA-sequencing Market Drivers

Figure 22. NGS-based RNA-sequencing Market Restraints

Figure 23. NGS-based RNA-sequencing Market Trends

Figure 24. Illumina Recent Developments and Future Plans

Figure 25. Thermo Fischer Scientific Recent Developments and Future Plans

Figure 26. Oxford Nanopore Recent Developments and Future Plans

Figure 27. Agilent Technologies Recent Developments and Future Plans

Figure 28. BGI Recent Developments and Future Plans

Figure 29. PerkinElmer Recent Developments and Future Plans

Figure 30. QIAGEN Recent Developments and Future Plans

Figure 31. Eurofins Scientific Recent Developments and Future Plans

Figure 32. Roche Recent Developments and Future Plans

Figure 33. Takara Bio Recent Developments and Future Plans

Figure 34. GENEWIZ Recent Developments and Future Plans

Figure 35. Hamilton Recent Developments and Future Plans

Figure 36. Macrogen Recent Developments and Future Plans

Figure 37. Zymo Research Recent Developments and Future Plans

Figure 38. Tecan Genomics Recent Developments and Future Plans

Figure 39. Global NGS-based RNA-sequencing Revenue Share by Players in 2020

Figure 40. NGS-based RNA-sequencing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 41. Global Top 3 Players NGS-based RNA-sequencing Revenue Market Share in 2020

Figure 42. Global Top 10 Players NGS-based RNA-sequencing Revenue Market Share in 2020

Figure 43. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 44. Global NGS-based RNA-sequencing Revenue Share by Type in 2020

Figure 45. Global NGS-based RNA-sequencing Market Share Forecast by Type (2021-2026)

Figure 46. Global NGS-based RNA-sequencing Revenue Share by Application in 2020

Figure 47. Global NGS-based RNA-sequencing Market Share Forecast by Application (2021-2026)

Figure 48. North America NGS-based RNA-sequencing Sales Market Share by Type (2016-2026)

Figure 49. North America NGS-based RNA-sequencing Sales Market Share by Application (2016-2026)

Figure 50. North America NGS-based RNA-sequencing Revenue Market Share by Country (2016-2026)

Figure 51. United States NGS-based RNA-sequencing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 52. Canada NGS-based RNA-sequencing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 53. Mexico NGS-based RNA-sequencing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 54. Europe NGS-based RNA-sequencing Sales Market Share by Type (2016-2026)

Figure 55. Europe NGS-based RNA-sequencing Sales Market Share by Application (2016-2026)

Figure 56. Europe NGS-based RNA-sequencing Revenue Market Share by Country (2016-2026)

Figure 57. Germany NGS-based RNA-sequencing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 58. France NGS-based RNA-sequencing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 59. United Kingdom NGS-based RNA-sequencing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 60. Russia NGS-based RNA-sequencing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 61. Italy NGS-based RNA-sequencing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 62. Asia-Pacific NGS-based RNA-sequencing Sales Market Share by Type (2016-2026)

Figure 63. Asia-Pacific NGS-based RNA-sequencing Sales Market Share by Application (2016-2026)

Figure 64. Asia-Pacific NGS-based RNA-sequencing Revenue Market Share by Region (2016-2026)

Figure 65. China NGS-based RNA-sequencing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 66. Japan NGS-based RNA-sequencing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 67. South Korea NGS-based RNA-sequencing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 68. India NGS-based RNA-sequencing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 69. Southeast Asia NGS-based RNA-sequencing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 70. Australia NGS-based RNA-sequencing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 71. South America NGS-based RNA-sequencing Sales Market Share by Type (2016-2026)

Figure 72. South America NGS-based RNA-sequencing Sales Market Share by Application (2016-2026)

Figure 73. South America NGS-based RNA-sequencing Revenue Market Share by Country (2016-2026)

Figure 74. Brazil NGS-based RNA-sequencing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 75. Argentina NGS-based RNA-sequencing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 76. Middle East and Africa NGS-based RNA-sequencing Sales Market Share by Type (2016-2026)

Figure 77. Middle East and Africa NGS-based RNA-sequencing Sales Market Share by Application (2016-2026)

Figure 78. Middle East and Africa NGS-based RNA-sequencing Revenue Market Share by Country (2016-2026)

Figure 79. Turkey NGS-based RNA-sequencing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 80. Saudi Arabia NGS-based RNA-sequencing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 81. UAE NGS-based RNA-sequencing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 82. Methodology

Figure 83. Research Process and Data Source